SynDermix-logo-thumb

Well beyond tomorrow

Innovating to treat and defend the body's frontiers

SynDermix is a Swiss clinical-stage biotechnology company that develops leading-edge treatments in areas of unmet medical need. Powered by three platform technologies and defined by synergism, our focus is on frontier pipeline candidates that target disorders affecting the epithelial tissues of the human body and which improve their well-being.

About us

Our 3 most advanced pipeline candidates